Key result
Primed CD3+ T cells directly clear measles virus infection from brain tissue using a noncytolytic IL-12- and IFN-gamma-dependent mechanism that relies on Jak/STAT signaling.
Why the study?
Does application of primed CD3+ T cells or IFN-gamma reduce measles virus RNA levels in infected organotypic brain explants?
Does application of primed CD3+ T cells or IFN-gamma reduce measles virus RNA levels in infected organotypic brain explants?
Effect estimate: 89% reduction in viral RNA load
p-value: p=<0.0001
Primed T cells clear measles virus from brain tissue via a noncytolytic, IL-12- and IFN-γ-dependent mechanism utilizing Jak/STAT signaling.
Should not inform clinical use in humans; hypothesis-generating for noncytolytic T-cell therapies in CNS viral infections.
Genetic studies with immunocompetent mice show the importance of both T cells and gamma interferon (IFN-γ) for survival of a measles virus (MV) challenge; however, the direct role of T cells and IFN-γ within the MV-infected brain has not been addressed. Organotypic brain explants represent a successful ex vivo system to define central nervous system (CNS)-specific mechanisms of leukocyte migration, activation, and MV clearance. Within the heterogeneous, brain-derived, primed leukocyte population which reduced MV RNA levels in brain explants by 60%, CD3 T cells are the active antiviral cells, as purified CD3-positive cells are highly antiviral and CD3-negative leukocytes are unable to reduce the viral load. Neutralization of CCL5 and CXCL10 decreases leukocyte migration to areas of infection by 70%. However, despite chemokines directing the migration of T cells to infected neurons, chemokine neutralization revealed that migration is not required for viral clearance, suggesting a cytokine-mediated antiviral mechanism. In accordance with our hypothesis, the ability of leukocytes to clear the virus is abrogated when explants are treated with anti-IFN-γ neutralizing antibodies. IFN-γ applied to infected slices in the absence of primed leukocytes reduces the viral load by more than 80%; therefore, in brain tissue, IFN-γ is both necessary and sufficient to clear MV. Secretion of IFN-γ is stimulated by interleukin-12 (IL-12) in the brain, as neutralization of IL-12 results in loss of antiviral activity and stimulation of leukocytes with IL-12/IL-18 enhances their immune effector function of viral clearance. MV-primed leukocytes can reduce both West Nile and mouse hepatitis viral RNAs, indicating that cytokine-mediated viral clearance occurs in an antigen-independent manner. The IFN-γ signal is transduced within the brain explant by the Jak/STAT signaling pathway, as inhibition of Jak kinases results in a loss of antiviral activity driven by either brain-derived leukocytes or recombinant IFN-γ. These results reveal that primed T cells directly act to clear MV infection of the brain by using a noncytolytic IL-12- and IFN-γ-dependent mechanism in the CNS and that this mechanism relies upon Jak/STAT signaling.
No takes yet. Share an insight, caveat, or question.
Park et al. (2011) studied Measles virus encephalitis (preclinical model). Brain-derived leukocytes (CD3+ T cells) and IFN-gamma vs. Untreated control or isotype control antibodies was evaluated on Viral RNA load reduction (89% reduction in viral RNA load, p=<0.0001). Primed CD3+ T cells directly clear measles virus infection from brain tissue using a noncytolytic IL-12- and IFN-gamma-dependent mechanism that relies on Jak/STAT signaling.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: